GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Study Identifies ZFP612 Protein’s Role in Repressing Il1rl1 Gene to Modulate Neuropathic Pain

by GOAI
Share To

A recent study has identified a potential mechanism for alleviating neuropathic pain through epigenetic regulation. Researchers have found that the protein ZFP612 plays a key role in repressing the gene Il1rl1, which is associated with pain signaling. This discovery sheds light on how molecular processes can influence chronic pain conditions, offering new insights into potential therapeutic strategies.

The study, published in *Nature Communications* by Ma et al., highlights how ZFP612 suppresses Il1rl1 expression to modulate neuropathic pain responses. Neuropathic pain, which affects millions globally, often results from nerve damage and remains difficult to treat effectively. The research explores the epigenetic mechanisms underlying this condition and demonstrates how targeting specific genes like Il1rl1 could provide relief. These findings contribute to a growing body of knowledge aimed at understanding and addressing persistent pain disorders through molecular neuroscience approaches.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Phosphorylation and Ubiquitination Mechanisms Linked to Rosacea Pathogenesis
2026-10-10
Malin and Goetz Updates SPF 30 Mineral Sunscreen Documentation on DailyMed
2026-10-09
Henry Schein Updates Vitamin A & D Ointment Product Documentation on DailyMed
2026-10-09
Mary Kay Updates Clear Proof Acne Treatment Gel Labeling in DailyMed Database
2026-10-09
Dechra Veterinary Products Updates Muricin Ointment Documentation on DailyMed
2026-10-09
Cardinal Health Updates LEADER Daily Moisturizer Product Documentation on DailyMed
2026-10-09
S.S.S. Company Updates Curasore Pramoxine Hydrochloride Product Information on DailyMed
2026-10-09
EVENT
Scroll to Top